Effect of hepatic cirrhosis on the pharmacodynamics and pharmacokinetics of mivacurium in humans.
Levy
G
G
Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, Amherst 14260.
D006207:Half-Life; D006801:Humans; D007546:Isoquinolines / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008103:Liver Cirrhosis / Q000378:metabolism*; D000077590:Mivacurium; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*
D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D000077590:Mivacurium